MEDICRES 2020 GOOD CARDIOLOGY RESEARCH, İstanbul, Türkiye, 24 - 31 Ekim 2020
Technology is good enough to detect asymptomatic AF and maybe even to predict the risk of AF Next steps would be on clinical indications. We need targeting trials. Yes AF; then what ? AI based "screening and follow-up platforms" Better risk assessment compared to CHA2DS2-VASc or other risc scoring systems. Change in our understanding of; AHREs, SCAF or other definitions